Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HQK-1001 in Beta Thalassemia Intermedia
NCT01642758Phase 2Completed
- Sponsor
- Boston University
- Start
- May 2012
- Primary completion
- Nov 2012
- Countries
- 1
01
Overview
A Phase 2 trial of sodium 2,2-dimethylbutyrate in beta-thalassemia intermedia, sponsored by Boston University. Started May 2012; status: completed.
02
Drugs
sodium 2,2-dimethylbutyrate
03
Conditions
beta-thalassemia intermedia
Beyond the preview
Go deeper on NCT01642758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01642758.